Results 1 to 10 of about 295,979 (212)
Some of the next articles are maybe not open access.
Systemic lupus erythematosus and lupus nephritis
Nature Reviews Drug Discovery, 2014The late-stage pipeline for systemic lupus erythematosus (SLE) and lupus nephritis (LN) contains biologics and small-molecule drugs for a broad range of different targets. Koutsokeras and Healy discuss their likely impact on the future SLE and LN market.
Toli, Koutsokeras, Tina, Healy
exaly +3 more sources
The Lupus Susceptibility Locus Sgp3 Encodes the Suppressor of Endogenous Retrovirus Expression SNERV
Immunity, 2019Manabu Taura +2 more
exaly
Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus
Nature Genetics, 2011Safiya Al Abrawi +2 more
exaly
Impact of an online lupus self-management programme in an established, population-based cohort of adults with diagnosed SLE: a mixed-methods study [PDF]
Objective Strategies to Embrace Living with Lupus Fearlessly (SELF) is an online self-management education programme for people with SLE. This mixed-methods study examines SELF’s impact on patient-reported outcomes while assessing implementation outcomes
S Sam Lim +9 more
doaj +2 more sources
Living with systemic lupus erythematosus in 2020: a European patient survey
Objective The aim of this study was to analyse the 2020 burden of Systemic Lupus Erythematosus (SLE) in Europe, from the patients’ perspective.Methods In May 2020, Lupus Europe, the European umbrella patient association for SLE, designed and disseminated
Alain Cornet +3 more
doaj +1 more source
Membrane and Soluble CD137 in Systemic Lupus Erythematosus: Role as Biomarkers for Disease Activity
Objective. The role of T cells in the pathogenesis of systemic lupus erythematosus (SLE) has recently gained attention. Costimulatory molecules are membrane proteins strictly associated with T-cell receptor (TCR), acting by activating or inhibiting T ...
Fulvia Ceccarelli +8 more
doaj +1 more source

